July 18th, 2008
FREE SEMINAR
September 17, 2008
9-5pm
Listen to key European experts offering a wide spectrum of in-depth knowlsedge and experience in clinical trials in Europe.
Understand the benefits of conducting preclinical and clinical activities in Europe.
Discover new opportunities and challenges in logistics of outsourcing pre-clinical and clinical developments to European service providers.
Overcome the differences between FDA and EMEA.
This is a free seminar organized by Aresa and coordinated by IDISUS
September 17, 2008
9 - 5pm
Princeton University
Friend Center
Corner of WIlliam Street & Olden Street
Room #113
Princeton, NJ 08544
for more information click here http://www.idis-us.com/seminar/newsletter-seminar-aresa.html
Posted in General information | No Comments »
July 10th, 2008
Exponent Presents:
Philadelphia Medical Device Seminar Series
Wednesday, July 16, 2008
8:00am - 9:00am
(continental breakfast @ 7:30am)
Is your company worth the risk? Making your start-up device or biotech company attractive for investors.
David W. Anderson
President & CEO, Gentis, Inc.
David R. King
Venture Partner, Quaker BioVentures
What attracts venture capitalists to fund certain start-ups and not others? Many of today’s leading medical device and biotech companies began as start-ups funded by VCs who took a risk. This seminar will provide a forum for discussion of how lower-risk strategies combined with successful commercial marketing plans can be achieved to help entrepreneurs attract the capital vital to a start-up’s success. Members of the business community who have played critical roles in bringing start-ups to fruition will provide expertise on this subject.
Highlights that will be discussed by this panel include:
- The real-life experiences of CEOs in growing an early-stage company
- What criteria do investors use to evaluate a biotech or device start-up?
- At what stage should VCs be approached?
- What concerns VCs when considering their next investment?
- How important is it for the start-up to have other products in the pipeline?
- What role does patent protection play in the consideration of funding?
- How to differentiate your start-up to make it attractive for funding
Union League
140 South Broad Street
Philadelphia, PA
Seminar is FREE!
Questions?
Please call 215-594-8800 or e-mail mcle@exponent.com
Posted in Events, Start Ups | No Comments »
May 22nd, 2008
Wednesday, June 25th
Continental Breakfast:
9:30am
Speaker:
Mike McCann
10:00 - 11:00am
Science Center
Fuller Conference Room
3701 Market Street, 3rd Floor
Philadelphia, PA 19104
Learn how your company can obtain up tp $100,000 in tradable tax credits from the Commonwealth Tax Program.
A seminar for:
~ Start-up Company CEOs and Financial Professionals
Why You Should Attend:
~ Learn how to convert your R&D expenses and up to $100,000 in KIZ Tax Credits
~ Explore creative ways to increase your KIZ Tax Credit through grant revenue
~ Understand the Tax Advantages of locating in a KOZ
Mike McCann of MVM Associates will explain the various Commonwealth of PA tax credit programs and how your company can access them. MVM is on the forefront of assisting PA technology firms in the implementation of the transferable KIZ Tax Credit. Least year, MVM helped 8 UC KIZ companies leverage over $585,000 in tradable tax credits. MVM also helps companies identify, win, and manage other grants and tax credits available at the state, local and federal level.
This even is free, but you mst register to attend. Call Kristen Fitch at 215-966-6156 or e-mail kfitch@uckiz.com
Posted in Events, Funding, General information | No Comments »
May 1st, 2008
April 23, 2008
Yvonne Paterson, Department of Microbiology
University of Pennsylvania
Click here to watch the video!
Posted in Events, General information, Start Ups | No Comments »
April 2nd, 2008
click here to view the flyer!
Join the partners of the University City KIZ to
learn more about tech transfer best practices.
Wednesday, May 14th
4 - 7:30pm
Dinner and networking
6:00pm
University of the Sciences in Philadelphia
McNeil Science and Technology Auditorium
43rd Street & Woodland Avenue
SPEAKERS
Philip P. Gerbino, President
University of the Sciences in Philadelphia
Robert McGrath, Associate Vice Provost
Drexel University
Barbara Schilberg, Managing Director & CEO
BioAdvance
Stephen Tang, President & CEO
Science Center
Katherin Chou, Executive Director of Technology Tranfer
Thomas Jefferson University
Shanaz Tejani-Butt, Associate Dean of Graduate Studies
University of the Sciences in Philadelphia
M. Gary Sayed, Provost & Senior VP for Academic Affairs
University of the Sciences in Philadelphia
This event is free, but you must register to attend. Please visit http://www.usp.edu/research/registration.aspx to register.
Posted in Events, General information, Start Ups | No Comments »
March 6th, 2008
Navigating the FDA Approval Process
The approval system for drugs and medical devices in the US is one of the most rigorous in the world.
Join us for an overview of FDA compliance of Medical Devices and learn:
- How does the FDA make decisions about the level of regulation to apply?
- What strategies can you use to optimize the time of FDA clearance?
- What are the key enforcement trends at the FDA?
- How can you build a solid long-term relationship with the agency?
Seminar Details:
Janice Hogan
March 26, 2008
5:30 - 7pm
Science Center
Fuller Conference Room
3701 Market Street, 3rd Floor
If you would like to attend, please RSVP to Kristen Fitch at 215-966-6156 or e-mail kfitch@uckiz.com.
Posted in Events, General information | No Comments »
February 27th, 2008
Posted in Events | No Comments »
February 13th, 2008
Pharmaceutical Preformulation: A Stop Along the Drug Development Superhighway
March 18th
Speaker:
John Higgins, PhD
Senior Investigator
Merck Pharmaceutical R&D
In the 1960’s, pharmaceutical Preformulation studies began to be implemented, where the physical and chemical properties of a new drug were characterized in order to help predict difficulties that were likely to arise during development.
This session will:
- Explore how preformulation studies also provide expectations on a drug’s in vivo behavior in the first human clinical trils
- Describe this widely practiced discipline with examples from laboratories from large pharma
- Discuss insights on careers in the pharmaceutical sciences
Dr. Higgins received a BS in biochemistry from Albright College and his PhD in organic chemistry from Brown University. After completing a Postdoctoral Fellowship at teh Sloan-Kattering Cancer Institute, he joined Medicinal Chemistry Discovery Group at Johnson Matthey Biomedical. With nearly 20 years experience in the pharmaceutical industry, Dr. Higgins is currently Senior Research Investigator at Merck Research Labs, where he leads a Lead Optimization Group at the interface of Discovery and Development. He is co-inventor on 12 US Patents and suthor of numorous publications and book chapters in the fields of organic, solid state & medicinal chemistry and drug delivery.
Click here to watch the video!
Posted in Events | No Comments »
February 12th, 2008
March 3rd
Speaker:
Chris Laing, MRCVS, PhD
Director
Clinical & Scientific Projects
University City Science Center
Join the UC KIZ and Chris Laing for a practical overview of SBIR/STTR grants, designed to help you understand the mechanics of these federal programs, and to help you write more successful applications.
- Learn how to identify appropriate SBIR/STTR programs for your company
- Understand the differences between federal SBIR/STTR agencies
- Get answers to your questions about the programs and their rules
- Walk through an application, and hear tips on writing and submitting competitive proposals
Christopher Laing, PhD is the Director of Clinical and Scientific Projects at the University City Science Center. Dr. Laing has worked closely with more than 20 start-up biotech and instrumentation companies. Dr. Laing provides guidance in early business nad product development planning, in securing the resources required to retire technology development risks, and in providing a technical communication stream that includes publications, marketing, and applications to federal agencies including NIH, NSF, DoD, and the FDA. He has helped raise more that $20 million equity-sparing federal funding to directly support product development by small technology companies. With the UCSC team and its partners, Dr. Laing seeks to support early companies across the full spectrum of their management, regulatory, technical, pre-clinical development activitivies.
Click below to view the video!
http://uckiz.com/Video/Laing%203-3-08%20LoRes.mov
Posted in Events | No Comments »